Emerging Markets — Net Sales
Boston Scientific Emerging Markets — Net Sales increased by 0.9% to $772.00M in Q4 2025 compared to the prior quarter. Year-over-year, this metric grew by 15.6%, from $668.00M to $772.00M. Over 4 years (FY 2021 to FY 2025), Emerging Markets — Net Sales shows an upward trend with a 20.2% CAGR. This is a positive signal — higher values indicate stronger performance for this metric.
Analysis
How to read this metric
An increase indicates successful market penetration and rising adoption of medical technologies in developing regions, while a decrease may signal competitive pressure, economic volatility, or regulatory hurdles in those territories.
Detailed definition
This metric represents the total revenue generated from the sale of medical devices and services within designated high-...
Peer comparison
Peers in the medical device industry typically report this as a component of international or regional revenue, often benchmarked against total global sales growth rates.
bsx_segment_emerging_markets_net_salesHistorical Data
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $359.00M | $354.00M | $399.00M | $390.00M | $427.00M | $454.00M | $444.00M | $529.00M | $592.00M | $594.00M | $595.00M | $648.00M | $680.00M | $684.00M | $668.00M | $690.00M | $758.00M | $765.00M | $772.00M |
| QoQ Change | — | -1.4% | +12.7% | -2.3% | +9.5% | +6.3% | -2.2% | +19.1% | +11.9% | +0.3% | +0.2% | +8.9% | +4.9% | +0.6% | -2.3% | +3.3% | +9.9% | +0.9% | +0.9% |
| YoY Change | — | — | — | — | +18.9% | +28.2% | +11.3% | +35.6% | +38.6% | +30.8% | +34.0% | +22.5% | +14.9% | +15.2% | +12.3% | +6.5% | +11.5% | +11.8% | +15.6% |
Similar Metrics at Other Companies
Frequently Asked Questions
- What is Boston Scientific's emerging markets — net sales?
- Boston Scientific (BSX) reported emerging markets — net sales of $772.00M in Q4 2025.
- How has Boston Scientific's emerging markets — net sales changed year-over-year?
- Boston Scientific's emerging markets — net sales increased by 15.6% year-over-year, from $668.00M to $772.00M.
- What is the long-term trend for Boston Scientific's emerging markets — net sales?
- Over 4 years (2021 to 2025), Boston Scientific's emerging markets — net sales has grown at a 20.2% compound annual growth rate (CAGR), from $1.43B to $2.99B.
- What does emerging markets — net sales mean?
- Total revenue earned from sales in developing international markets.